Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...

Edwards Lifesciences reports strong Q3 2025 earnings, raises guidance, and highlights growth in heart therapies.

Get key insights from Bristol-Myers Squibb's Q3 2025 earnings call—growth highlights, raised guidance, and strategic pipeline updates.

New UC San Diego research shows that pharmacists can play a crucial role in helping people with cancer and diabetes better ...

From streaming video and syncing data to connecting applications, the cloud plays an increasingly pivotal role in helping ...

KEGE Center for ADHD, a psychiatric practice specializing in evidence-based ADHD evaluation and coordinated care, has announced a series of clinical enhancements designed to improve patient access, ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

While acknowledging the challenges to using SDOH information in practice, a presenter at the American College of Rheumatology ...

Mast cell tumors are prevalent skin neoplasms observed in veterinary clinical practice, particularly affecting both dogs and cats. Over the years, rigorous ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...